Hyloris Annonce ses Résultats Financiers Annuels le 14 mars 2024
March 08, 2024 01:00 ET
|
Hyloris Pharmaceuticals SA
Liège, Belgique – le 8 mars 2024, 07:00 heures CET - Information non réglementée - Hyloris Pharmaceuticals SA (Euronext Bruxelles : HYL), une société biopharmaceutique spécialisée qui s'engage à...
Hyloris to Report 2023 Full-Year Results on 14 March 2024
March 08, 2024 01:00 ET
|
Hyloris Pharmaceuticals SA
Liège, Belgium – 08 February 2024, 07:00 AM CET – Non-regulated information – Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a specialty biopharma company committed to addressing unmet medical...
PerimeterX Celebrates Milestones at the Close of its Fiscal Year
March 03, 2022 10:00 ET
|
PerimeterX
SAN MATEO, Calif., March 03, 2022 (GLOBE NEWSWIRE) -- PerimeterX, the leading provider of solutions that detect and stop the abuse of identity and account information on the web, today announced the...